New Hampshire · 2026 Regular Session · Bill
HB 1321: relative to the regulation of the provision of elective intravenous therapy.
Did not advance Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
- Did not advance
Last official action: ·Record last updated:
Plain-language summary
HB 1321 is a bill introduced in the New Hampshire House on December 1, 2025. According to its official title, it concerns: relative to the regulation of the provision of elective intravenous therapy. Primary sponsor: Alice Wade (Democratic). It lists 1 additional sponsor. Most recent recorded action (March 5, 2026): Inexpedient to Legislate: MA VV 03/05/2026 HJ 6 P. 19.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Alice Wade | Primary sponsor | Democratic | House | Strafford 15 |
| Heath Howard | Co-sponsor | Democratic | House | Strafford 4 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Inexpedient to Legislate: MA VV 03/05/2026 HJ 6 P. 19
- Committee Report: Inexpedient to Legislate 02/18/2026 (Vote 18-0; CC) HC 9 P. 16
- Executive Session: 02/18/2026 02:30 pm GP 158
- Public Hearing: 02/11/2026 10:30 am GP 158
- Introduced 01/07/2026 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 15